On May 4, Marina Litvin, MD, attended and spoke at the Midwest Cystic Fibrosis Consortium, which took place in Kansas City, Missouri. Bringing together cystic fibrosis clinicians and researchers, the event promotes collaboration and discussion on topics surrounding the treatment of the disease.
At the consortium, Dr. Litvin gave a speech during the breakout sessions, titled “Overnutrition in the era of highly effective modulators.”
It is a very exciting time for advances in therapies for patients with cystic fibrosis. However, with the more targeted, highly effective corrector and modulator drug therapy, patients with cystic fibrosis are experiencing overnutrition, obesity and other features of metabolic syndrome at a much higher rate than previously. This changing landscape poses added complexity to the comprehensive care of our patients with cystic fibrosis, and optimal management approaches and treatment goals require additional research.
Marina Litvin, MD